Sartorius Stedim Valuation
| 56S1 Stock | EUR 198.25 1.10 0.56% |
At this time, the company appears to be overvalued. Sartorius Stedim Biotech has a current Real Value of €162.32 per share. The regular price of the company is €198.25. Our model measures the value of Sartorius Stedim Biotech from inspecting the company fundamentals such as Return On Equity of 0.41, shares outstanding of 92.17 M, and Operating Margin of 0.32 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Sartorius Stedim's price fluctuation is very steady at this time. Calculation of the real value of Sartorius Stedim Biotech is based on 3 months time horizon. Increasing Sartorius Stedim's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sartorius stock is determined by what a typical buyer is willing to pay for full or partial control of Sartorius Stedim Biotech. Since Sartorius Stedim is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sartorius Stock. However, Sartorius Stedim's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 198.25 | Real 162.32 | Hype 198.25 | Naive 199.99 |
The real value of Sartorius Stock, also known as its intrinsic value, is the underlying worth of Sartorius Stedim Biotech Company, which is reflected in its stock price. It is based on Sartorius Stedim's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Sartorius Stedim's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Sartorius Stedim Biotech helps investors to forecast how Sartorius stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sartorius Stedim more accurately as focusing exclusively on Sartorius Stedim's fundamentals will not take into account other important factors: Sartorius Stedim Total Value Analysis
Sartorius Stedim Biotech is presently projected to have takeover price of 31.28 B with market capitalization of 28.22 B, debt of 1.02 B, and cash on hands of 164.6 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sartorius Stedim fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
31.28 B | 28.22 B | 1.02 B | 164.6 M |
Sartorius Stedim Investor Information
About 74.0% of the company shares are owned by insiders or employees . The company has Price/Earnings (P/E) ratio of 110.44. Sartorius Stedim Biotech recorded earning per share (EPS) of 9.32. The entity last dividend was issued on the 30th of March 2023. The firm had 6:1 split on the 6th of May 2016. Sartorius Stedim Biotech is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Sartorius Stedim Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sartorius Stedim has an asset utilization ratio of 68.95 percent. This implies that the Company is making €0.69 for each dollar of assets. An increasing asset utilization means that Sartorius Stedim Biotech is more efficient with each dollar of assets it utilizes for everyday operations.Sartorius Stedim Ownership Allocation
Sartorius Stedim Biotech shows a total of 92.17 Million outstanding shares. Sartorius Stedim Biotech has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 73.81 % of Sartorius Stedim outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sartorius Stedim Profitability Analysis
The company reported the revenue of 3.49 B. Net Income was 876.1 M with profit before overhead, payroll, taxes, and interest of 1.83 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sartorius Stedim's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sartorius Stedim and how it compares across the competition.
About Sartorius Stedim Valuation
The stock valuation mechanism determines Sartorius Stedim's current worth on a weekly basis. Our valuation model uses a comparative analysis of Sartorius Stedim. We calculate exposure to Sartorius Stedim's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sartorius Stedim's related companies.Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. SARTOR STED operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8200 people.
8 Steps to conduct Sartorius Stedim's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Sartorius Stedim's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Sartorius Stedim's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Sartorius Stedim's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Sartorius Stedim's revenue streams: Identify Sartorius Stedim's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Sartorius Stedim's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Sartorius Stedim's growth potential: Evaluate Sartorius Stedim's management, business model, and growth potential.
- Determine Sartorius Stedim's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Sartorius Stedim's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Sartorius Stock analysis
When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |